SK Chemicals Co., Ltd.

The European Medicines Agency has recommended granting pan-EU approval to Almirall / Eli Lilly ’s eczema drug Ebglyss (lebrikizumab) and Novartis ’s protein kinase inhibitor Finlee (dabrafenib) for

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Kelun, Merck Ink Third Cancer Coll

TiumBio Co., Ltd. is one of a number of South Korean companies actively operating a business and exploring opportunities in Australia to benefit from the country's generous R&D tax incentives and glo

SK Bioscience Co. Ltd. is set to move its next-generation COVID-19 vaccine candidate GBP510 into a Phase III trial with the help of unprecedented global development support, marking the first time for